These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28116609)

  • 21. Investigation of cutaneous penetration properties of stearic acid loaded to dendritic core-multi-shell (CMS) nanocarriers.
    Lohan SB; Icken N; Teutloff C; Saeidpour S; Bittl R; Lademann J; Fleige E; Haag R; Haag SF; Meinke MC
    Int J Pharm; 2016 Mar; 501(1-2):271-7. PubMed ID: 26853315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudoceramide stimulates peroxisome proliferator-activated receptor-α expression in a murine model of atopic dermatitis: molecular basis underlying the anti-inflammatory effect and the preventive effect against steroid-induced barrier impairment.
    Lee SE; Jung MK; Oh SJ; Jeong SK; Lee SH
    Arch Dermatol Res; 2015 Nov; 307(9):781-92. PubMed ID: 26121942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of an ester-based core-multishell (CMS) nanocarrier for the topical application at the oral mucosa.
    Dommisch H; Stolte KN; Jager J; Vogel K; Müller R; Hedtrich S; Unbehauen M; Haag R; Danker K
    Clin Oral Investig; 2021 Oct; 25(10):5795-5805. PubMed ID: 33821321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ceramide profiles of the uninvolved skin in atopic dermatitis and psoriasis are comparable to those of healthy skin.
    Farwanah H; Raith K; Neubert RH; Wohlrab J
    Arch Dermatol Res; 2005 May; 296(11):514-21. PubMed ID: 15803327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serine Protease-Mediated Cutaneous Inflammation: Characterization of an Ex Vivo Skin Model for the Assessment of Dexamethasone-Loaded Core Multishell-Nanocarriers.
    Frombach J; Rancan F; Kübrich K; Schumacher F; Unbehauen M; Blume-Peytavi U; Haag R; Kleuser B; Sabat R; Wolk K; Vogt A
    Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32927792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A lamellar body mimetic system for the treatment of oxazolone-induced atopic dermatitis in hairless mice.
    Moner V; Fernández E; Calpena AC; Garcia-Herrera A; Cócera M; López O
    J Dermatol Sci; 2018 May; 90(2):172-179. PubMed ID: 29395580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel flexible vesicles based topical formulation of levocetirizine: in vivo evaluation using oxazolone-induced atopic dermatitis in murine model.
    Goindi S; Kumar G; Kaur A
    J Liposome Res; 2014 Sep; 24(3):249-57. PubMed ID: 24646413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The lipid alterations in the stratum corneum of dogs with atopic dermatitis are alleviated by topical application of a sphingolipid-containing emulsion.
    Popa I; Remoue N; Osta B; Pin D; Gatto H; Haftek M; Portoukalian J
    Clin Exp Dermatol; 2012 Aug; 37(6):665-71. PubMed ID: 22360796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymeric micelle nanocarriers for the cutaneous delivery of tacrolimus: a targeted approach for the treatment of psoriasis.
    Lapteva M; Mondon K; Möller M; Gurny R; Kalia YN
    Mol Pharm; 2014 Sep; 11(9):2989-3001. PubMed ID: 25057896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanocarrier-based dermopharmaceutical formulations for the topical management of atopic dermatitis.
    Cláudia Paiva-Santos A; Gama M; Peixoto D; Sousa-Oliveira I; Ferreira-Faria I; Zeinali M; Abbaspour-Ravasjani S; Mascarenhas-Melo F; Hamishehkar H; Veiga F
    Int J Pharm; 2022 Apr; 618():121656. PubMed ID: 35278601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice.
    Yamamoto M; Haruna T; Yasui K; Takahashi H; Iduhara M; Takaki S; Deguchi M; Arimura A
    Allergol Int; 2007 Jun; 56(2):139-48. PubMed ID: 17460441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the skin barrier abnormal in dogs with atopic dermatitis?
    Olivry T
    Vet Immunol Immunopathol; 2011 Nov; 144(1-2):11-6. PubMed ID: 21835476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vivo dermal pharmacokinetics, efficacy, and safety of skin targeting nanoparticles for corticosteroid treatment of atopic dermatitis.
    Siddique MI; Katas H; Amin MC; Ng SF; Zulfakar MH; Jamil A
    Int J Pharm; 2016 Jun; 507(1-2):72-82. PubMed ID: 27154252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is the Fractional Laser Still Effective in Assisting Cutaneous Macromolecule Delivery in Barrier-Deficient Skin? Psoriasis and Atopic Dermatitis as the Disease Models.
    Lee WR; Shen SC; Sung CT; Liu PY; Fang JY
    Pharm Res; 2018 Apr; 35(7):128. PubMed ID: 29700662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atopic dermatitis: studies of skin permeability and effectiveness of topical PUVA treatment.
    Ogawa H; Yoshiike T
    Pediatr Dermatol; 1992 Dec; 9(4):383-5. PubMed ID: 1492065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-Inflammatory Activities of Pentaherbs Formula, Berberine, Gallic Acid and Chlorogenic Acid in Atopic Dermatitis-Like Skin Inflammation.
    Tsang MS; Jiao D; Chan BC; Hon KL; Leung PC; Lau CB; Wong EC; Cheng L; Chan CK; Lam CW; Wong CK
    Molecules; 2016 Apr; 21(4):519. PubMed ID: 27104513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin?
    Imokawa G; Abe A; Jin K; Higaki Y; Kawashima M; Hidano A
    J Invest Dermatol; 1991 Apr; 96(4):523-6. PubMed ID: 2007790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyaluronic acid-cyclodextrin encapsulating paeonol for treatment of atopic dermatitis.
    Wang Y; Tang Z; Guo X; Zhao Y; Ren S; Zhang Z; Lv H
    Int J Pharm; 2022 Jul; 623():121916. PubMed ID: 35714817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dendritic nanoparticles for cutaneous drug delivery--testing in human skin and reconstructed human skin.
    Zoschke C; Schilrreff P; Romero EL; Brandner JM; Schafer-Korting M
    Curr Pharm Des; 2015; 21(20):2784-800. PubMed ID: 25925118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blockade of experimental atopic dermatitis via topical NF-kappaB decoy oligonucleotide.
    Dajee M; Muchamuel T; Schryver B; Oo A; Alleman-Sposeto J; De Vry CG; Prasad S; Ruhrmund D; Shyamsundar R; Mutnick D; Mai K; Le T; Parham C; Zhang J; Komuves L; Colby T; Hudak S; McEvoy LM; Ehrhardt RO
    J Invest Dermatol; 2006 Aug; 126(8):1792-803. PubMed ID: 16628194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.